izpis_h1_title_alt

Precocious puberty in a girl with 3-methylglutaconic aciduria type 1 (3-MGA-I) due to a novel AUH gene mutation
ID Bizjak, Neli (Avtor), ID Žerjav-Tanšek, Mojca (Avtor), ID Avbelj Stefanija, Magdalena (Avtor), ID Repič-Lampret, Barbka (Avtor), ID Mezek, Ajda (Avtor), ID Drole Torkar, Ana (Avtor), ID Battelino, Tadej (Avtor), ID Grošelj, Urh (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (497,33 KB)
MD5: 0ADFBEAD5C1DDC660C5143937303EF87
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S2214426920301373 Povezava se odpre v novem oknu

Izvleček
3-methylglutaconic aciduria type 1 (3-MGA-I) (MIM ID #250950) is an ultra-rare, autosomal recessive organic aciduria, resulting from mutated AUH gene, leading to the deficient 3-methylglutaconyl-CoA hydratase (3-MGH). Only around 40 cases are previously reported, caused by a spectrum of 10 mutations. The clinical spectrum of 3-MGA-I in children is heterogeneous, varying from asymptomatic individuals to mild neurological impairment, speech delay, quadriplegia, dystonia, choreoathetoid movements, severe encephalopathy, psychomotor retardation, basal ganglia involvement. Early dietary treatment with leucine restriction and carnitine supplementation may be effective in improving neurological state in pediatric patients with 3- MGA-I. We presented a girl with 3-MGA-I due to novel AUH gene mutation (homozygous variant c.330 + 5G > A) and confirmed by almost undetectable 3-MGH-enzyme activity, who initially presented with central precocious puberty at an early age of 4.5 years. Precocious puberty might be associated with the 3-MGA-I, as is reported previously in some other metabolic disorders that result in pathologic accumulation of metabolites or toxic brain damage. Therapy with GnRH agonist triptorelin effectively arrested pubertal development.

Jezik:Angleški jezik
Ključne besede:3-MGA-I, 3-methylglutaconic aciduria type 1, precocious puberty, AUH gene, GnRH agonist, triptorelin
Vrsta gradiva:Članek v reviji
Tipologija:1.03 - Kratki znanstveni prispevek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2020
Št. strani:4 str.
Številčenje:Vol. 25, art. 100691
PID:20.500.12556/RUL-138435 Povezava se odpre v novem oknu
UDK:616-053.2
ISSN pri članku:2214-4269
DOI:10.1016/j.ymgmr.2020.100691 Povezava se odpre v novem oknu
COBISS.SI-ID:42454275 Povezava se odpre v novem oknu
Datum objave v RUL:20.07.2022
Število ogledov:425
Število prenosov:81
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Molecular genetics and metabolism reports
Založnik:Elsevier
ISSN:2214-4269
COBISS.SI-ID:520387097 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0343
Naslov:Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj